Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Prescient Therapeutics Limited has requested a trading halt for its securities on the Australian Securities Exchange pending an announcement related to a capital raise. The halt will remain in effect until normal trading resumes or the announcement is released to the market. This request is made to assist the company in managing its continuous disclosure obligations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-707
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- Prescient Therapeutics - Extension of Share Purchase Plan
- PTX Opens First U.S. Site for PTX-100 Phase 2a Trial
- Prescient Therapeutics Extends Share Purchase Plan
- Prescient Therapeutics Opens Share Purchase Plan
- Prescient Therapeutics Launches Share Purchase Plan for $7m
Later from Prescient Therapeutics
- Prescient announces results of SPP & Launches Placement
- June 2025 Quarterly Update and Appendix 4C
- Prescient successfully completes $3 million Placement
- Appendix 4E and 2025 Annual Report
- September Quarterly Updated and Appendix 4C
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics